Impact of umbelliferone (7-hydroxycoumarin) on hepatic marker enzymes in streptozotocin diabetic rats

Indian Journal of Pharmacology

Volumn 38, Issue 3, 2006, Pages 209-210

  Ramesh, B ^a   Pugalendi, K ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; GLIBENCLAMIDE; UMBELLIFERONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; GLUCONEOGENESIS; GLYCOGEN ANALYSIS; LIVER WEIGHT; MALE; NONHUMAN; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES;

EID: 33745138574     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.25813     Document Type: Article

References (9)

1. Gallou G, Ruelland A, Legras B, Maugendre D, Allanic H, Cloarec L. Plasma MDA in type 1 and type 2 diabetes. Clin Chim Acta 1993;214:227-34.
2. Hoult JRS, Paya M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol 1996;27:713-22.
3. Ramesh B, Pugalendi KV. Antihyperglycaemic effect of umbelliferone in STZ-diabetic rats. J Med Food 2005 (Accepted).
4. Ramesh B, Pugalendi KV. Impact of umbelliferone on erythrocyte redox status in STZ-diabetic rats. Yale J Biol Med (Accepted).
5. Rosalki SB, Rau D. Serum γ-glutamyl transpeptidase activity in alcoholism. Clin Chim Acta 1972;39:41-7.
6. Morales MA, Jabbay AJ, Tenenzi HP. Mutation affecting accumulation of glycogen. Neurospora News Lett 1973;20:24-5.
7. th ed. Appleton and Lange Stanford: Connecticut; 2000. p. 610.
8. Whitehead MW, Hawkes ND, Hainsworth I, Kingham JG. A prospective study of the causes of notably raised aspartate transaminase of liver origin. Gut 1999;45:129-33.
9. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998;21:732-7.